Cargando…

Amikacin Pharmacokinetics During Continuous Veno-Venous Hemodialysis

INTRODUCTION: Little is known about the pharmacokinetics of amikacin during continuous renal replacement therapy. METHODS: This prospective observational study included patients admitted to an academic medical center who received amikacin therapy while on continuous veno-venous hemodialysis (CVVHD)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lam, Simon W., Bauer, Seth R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2013
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4108101/ https://www.ncbi.nlm.nih.gov/pubmed/25134484 http://dx.doi.org/10.1007/s40121-013-0012-8

Ejemplares similares

Population Pharmacokinetics of Amikacin in Patients on Veno-Arterial Extracorporeal Membrane Oxygenation
por: Pressiat, Claire, et al.
Publicado: (2022)

Linezolid pharmacokinetics in critically ill patients with renal replacement therapy: comparison of equi-dose of continuous veno-venous haemofiltration with continuous veno-venous haemodiafiltration
por: Roger, C, et al.
Publicado: (2015)

Intermittent hemodialysis is superior to continuous veno-venous hemodialysis/hemodiafiltration to eliminate methanol and formate during treatment for methanol poisoning
por: Zakharov, Sergey, et al.
Publicado: (2014)

How continuous is continuous veno-venous haemofiltration?
por: Seidel, J, et al.
Publicado: (2006)

An evaluation of ciprofloxacin pharmacokinetics in critically ill patients undergoing continuous veno-venous haemodiafiltration
por: Spooner, Almath M, et al.
Publicado: (2011)

Levetiracetam Pharmacokinetics in a Patient with Intracranial Hemorrhage Undergoing Continuous Veno-Venous Hemofiltration
por: Van Matre, Edward T., et al.
Publicado: (2017)

Myoglobin clearance with continuous veno-venous hemodialysis using high cutoff dialyzer versus continuous veno-venous hemodiafiltration using high-flux dialyzer: a prospective randomized controlled trial
por: Weidhase, Lorenz, et al.
Publicado: (2020)

Meropenem pharmacokinetics in critically ill patients with or without burn treated with or without continuous veno‐venous haemofiltration
por: Selig, Daniel J., et al.
Publicado: (2021)

Use of Continuous Veno-Venous Hemodialysis (CVVHD) in Treatment of a Polytrauma Patient with Severe Hemophilia A
por: Zajączkowska, Renata, et al.
Publicado: (2022)

Variations of veno-arterial and mucosal-arterial CO(2) gap during continuous veno-venous hemodiafiltration
por: Chagnon, J-L, et al.
Publicado: (1998)

Catheter Port Reversal in Citrate Continuous Veno-Venous Hemofiltration
por: Boer, Willem, et al.
Publicado: (2021)

An open prospective study of amikacin pharmacokinetics in critically ill patients during treatment with continuous venovenous haemodiafiltration
por: D’Arcy, Deirdre M, et al.
Publicado: (2012)

A Pilot Randomized Controlled Trial of Comparison between Extended Daily Hemodialysis and Continuous Veno-venous Hemodialysis in Patients of Acute Kidney Injury with Septic Shock
por: Mishra, Shakti Bedanta, et al.
Publicado: (2017)

The immunological effects of continuous veno-venous haemodiafiltration in critically ill patients
por: Toft, Palle, et al.
Publicado: (1999)

Organ dysfunction during continuous veno-venous high cut-off hemodialysis in patients with septic acute kidney injury: A prospective observational study
por: Villa, Gianluca, et al.
Publicado: (2017)

Impact of Continuous Veno-Venous HemoDiALYsis with Regional Citrate Anticoagulation on Non-NUTRItional Calorie Balance in Patients on the ICU—The NUTRI-DAY Study
por: Wechselberger, Simon, et al.
Publicado: (2022)

Pharmacokinetics and Pharmacodynamics of Anti-infective Agents during Continuous Veno-venous Hemofiltration in Critically Ill Patients: Lessons Learned from an Ancillary Study of the IVOIRE Trial
por: Breilh, Dominique, et al.
Publicado: (2019)

The effect of continuous veno-venous haemofiltration on PiCCO(® )haemodynamic parameters
por: Mason, N, et al.
Publicado: (2005)

Continuous veno-venous hemofiltration in patients with metformin associated lactic acidosis
por: Bethlehem, C, et al.
Publicado: (2015)

Effectiveness of continuous veno-venous hemofiltration in the treatment of severe acute pancreatitis
por: Chen, Xuan, et al.
Publicado: (2019)

Evaluation of Amikacin Pharmacokinetics and Pharmacodynamics for Optimal Initial Dosing Regimen
por: Kato, Hideo, et al.
Publicado: (2017)

Predictive Performance of Population Pharmacokinetic Models for Amikacin in Term Neonates
por: Matcha, Saikumar, et al.
Publicado: (2023)

Amikacin Population Pharmacokinetics in Critically Ill Kuwaiti Patients
por: Matar, Kamal M., et al.
Publicado: (2013)

402 Pharmacokinetics of Extended vs Intermittent Intravenous Infusion of Meropenem in Critically Ill Patients Receiving Continuous Veno-Venous Haemofiltration
por: Frippiat, Frédéric, et al.
Publicado: (2014)

Reagent-free determination of amikacin content in amikacin sulfate injections by FTIR derivative spectroscopy in a continuous flow system
por: Ovalles, José F., et al.
Publicado: (2014)

CO(2) and O(2) removal during continuous veno-venous hemofiltration: a pilot study
por: Jonckheer, Joop, et al.
Publicado: (2019)

Treatment of Ventilator-associated Pneumonia with High-dose Colistin Under Continuous Veno-venous Hemofiltration
por: Spapen, Herbert, et al.
Publicado: (2019)

Hypophosphatemia during continuous veno-venous hemofiltration is associated with mortality in critically ill patients with acute kidney injury
por: Yang, Yi, et al.
Publicado: (2013)

Impact of daytime continuous veno-venous haemofiltration on treatment of paediatric tumour lysis syndrome
por: Wang, Yamei, et al.
Publicado: (2018)

Fundamentals of weaning veno-arterial and veno-venous extracorporeal membrane oxygenation
por: Tsiouris, Athanasios, et al.
Publicado: (2023)

Bleeding During Veno-Venous ECMO: Prevention and Treatment
por: Kalbhenn, Johannes, et al.
Publicado: (2022)

Veno-venous shunt-assisted cavopulmonary anastomosis
por: Kandakure, Pramod Reddy, et al.
Publicado: (2010)

Impaired Pharmacokinetics of Amiodarone under Veno-Venous Extracorporeal Membrane Oxygenation: From Bench to Bedside
por: Lescroart, Mickaël, et al.
Publicado: (2022)

Low bicarbonate replacement fluid normalizes metabolic alkalosis during continuous veno-venous hemofiltration with regional citrate anticoagulation
por: Köglberger, Paul, et al.
Publicado: (2021)

Amikacin pharmacokinetic/pharmacodynamic in intensive care unit: a prospective database
por: Logre, Elsa, et al.
Publicado: (2020)

Improvement of Oxygenation in Severe Acute Respiratory Distress Syndrome With High-Volume Continuous Veno-venous Hemofiltration
por: Yang, Wenmin, et al.
Publicado: (2016)

Successful Use of Continuous Veno-Venous Haemodialysis in a Case of Potential Lethal Caffeine Intoxication
por: Reimerink, Elles J., et al.
Publicado: (2023)

Evaluation of Amikacin Pharmacokinetics in Critically Ill Patients with Intra-abdominal Sepsis
por: Shahrami, Bita, et al.
Publicado: (2020)

Correction to: CO(2) and O(2) removal during continuous veno-venous hemofiltration: a pilot study
por: Jonckheer, Joop, et al.
Publicado: (2019)

Neutrophil gelatinase-associated lipocalin clearance during veno-venous continuous renal replacement therapy in critically ill patients
por: de Geus, Hilde R. H., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_eis5dhohkci2dkfh6gl9lv35ii